1. Lung cancer and Toll-like receptors

   • Aldo Pinto
   • Silvana Morello
   • Rosalinda Sorrentino

   Review 26 July 2011 Pages: 1211 - 1220

   

2. Therapeutic effects of metformin in breast cancer: involvement of the immune system?

   • Sarah Schott
   • Angelika Bierhaus
   • Christoph Domschke

   Opinion Paper 17 June 2011 Pages: 1221 - 1225

3. Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses

   • Sofia R. Gameiro
   • Jorge A. Caballero
   • James W. Hodge

   Original article 05 May 2011 Pages: 1227 - 1242

   

4. Increased PRAME antigen-specific killing of malignant cell lines by low avidity CTL clones, following treatment with 5-Aza-2′-Deoxycytidine

   • Mengyong Yan
   • Nourredine Himoudi
   • John Anderson

   original article 07 May 2011 Pages: 1243 - 1255

   

5. Immunotherapy eradicates metastases with reversible defects in MHC class I expression

   • Cristina Garrido
   • Irene Romero
   • Federico Garrido

   Original article 08 May 2011 Pages: 1257 - 1268

   

6. Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4⁺ T cells from patients with GI malignancy

   • Bethany L. Mundy-Bosse
   • Gregory S. Young
   • Gregory B. Lesinski

   Original article 21 May 2011 Pages: 1269 - 1279

   

7. Enhanced anti-tumor activity of interferon-alpha in SOCS1-deficient mice is mediated by CD4⁺ and CD8⁺ T cells

   • Kristan D. Guenterberg
   • Gregory B. Lesinski
   • William E. Carson III

   Original article 21 May 2011 Pages: 1281 - 1288

   

8. Gemcitabine enhances Wilms’ tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response

   • Akitaka Takahara
   • Shigeo Koido
   • Sadamu Homma

   Original article 24 May 2011 Pages: 1289 - 1297

   

9. MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing

   • Lei Bao
   • Kimberly Dunham
   • Kenneth Lucas

   Original article 28 May 2011 Pages: 1299 - 1307

   

10. Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODN

    • S. M. Geary
    • C. D. Lemke
    • A. K. Salem

    Original article 28 May 2011 Pages: 1309 - 1317

    

11. CTL recognition of a novel HLA-A*0201-binding peptide derived from glioblastoma multiforme tumor cells

    • Cheryl E. Myers
    • Paul Hanavan
    • Douglas F. Lake

    Original article 29 May 2011 Pages: 1319 - 1332

    

12. A peptide epitope derived from the cancer testis antigen HOM-MEL-40/SSX2 capable of inducing CD4⁺ and CD8⁺ T-cell as well as B-cell responses

    • Frank Neumann
    • Boris Kubuschok
    • Michael Pfreundschuh

    Original article 01 June 2011 Pages: 1333 - 1346

    

13. Skin tumor responsiveness to interleukin-2 treatment and CD8 Foxp3+ T cell expansion in an immunocompetent mouse model

    • David M. Foureau
    • Iain H. McKillop
    • Jonathan C. Salo

    Original Article 03 June 2011 Pages: 1347 - 1356

    

14. Obituary: Joseph Lustgarten, 1963–2011

    • Suzanne Ostrand-Rosenberg
    • Esteban Celis
    • Linda Sherman

    Short communication 17 August 2011 Pages: 1357 - 1358